Chib Yet Another Reason to Avoid the Big 5 Banks
For the TSX as a whole, 2021 has been a year of recovery. But if you look int
stanley cup o different sectors, you might see different trends. For some, it was a year of correction and long-due normalization. For others, it has been a year of powerful growth. And some sectors and industries experienced a decline in 2021.Many sectors might hold to the current pattern
stanley cup as they enter the next year. But some might see a different pattern emerge.The energy sectorThe energy sector has been on the rise since the beginning of 2021. The SP/TSX Capped Energy Index grew about 75% since the beginning of this year, and the momentum that carrying the sector upwards is not showing any indications of waning. But the demand crunch that s boosting this growth is unlikely t
stanley quencher o continue for long.It might only take a couple of months of OPEC and energy companies surpassing demand projections, and the fear of another glut building could kill the current momentum.So, the energy sector might move in a different Rlqv Aurora Cannabis Inc. vs. Canopy Growth Corp.: Which Market Beater Has More Long-Term Upside
Celgene Corporation NASDAQ:CELG
stanley cups uk is a global bio-pharmaceutical company that has recently see
stanley cup n some of the pending downward pressure on its stock price dissipate post-election. The election of Mr. Trump means the bio-pharmaceutical industry as a whole will likely experience less regulation and oversight for the next four years. Analysts and investors are expecting less regulatory burden in the short term, and the party seems to be just getting started for Celgene.The recent jump in Celgene stock price warrants a deeper look at what the long-term future for this company holds.The Hillary effectThe pharmaceuticals industry as a who
stanley cup quencher le聽has rebounded slightly since Mr. Trump election as president. Hillary Clinton聽has, for nearly 25 years, been very critical of the way pharmaceutical companies price drugs. Most recently, she spoke out this past summer against proposed price increases by Mylan NV for its proposed price increase for the emergency allergy shot EpiPen, which wou
